Reactivation of persistent Chlamydia trachomatis infection in cell culture.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 172978)

Published in Infect Immun on January 01, 1995

Authors

W L Beatty1, R P Morrison, G I Byrne

Author Affiliations

1: Department of Medical Microbiology and Immunology, University of Wisconsin, Madison 53706.

Articles citing this

Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest (2003) 3.04

Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78

Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A (2003) 1.95

Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog (2007) 1.33

HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev (2004) 1.32

Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect Immun (2000) 1.22

Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun (2001) 1.18

Chlamydia persistence -- a tool to dissect chlamydia--host interactions. Microbes Infect (2011) 1.17

Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. Antimicrob Agents Chemother (2005) 1.15

Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun (2001) 1.13

New insights into a persistent problem -- chlamydial infections. J Clin Invest (2003) 1.04

Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice. Microbes Infect (2012) 0.99

Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells. Infect Immun (1999) 0.99

Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Infect Immun (2000) 0.98

Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells. Infect Immun (2011) 0.93

Reconceptualizing the chlamydial inclusion as a pathogen-specified parasitic organelle: an expanded role for Inc proteins. Front Cell Infect Microbiol (2014) 0.92

Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J Clin Microbiol (2001) 0.90

Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method. Antimicrob Agents Chemother (1999) 0.90

Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection. Curr HIV Res (2012) 0.88

Kinematics of intracellular chlamydiae provide evidence for contact-dependent development. J Bacteriol (2009) 0.86

Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. BMC Infect Dis (2006) 0.86

Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release. Infect Immun (2011) 0.85

A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol. BMC Infect Dis (2013) 0.85

A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice. Infect Immun (1996) 0.84

Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? Med Microbiol Immunol (2010) 0.84

Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture. Infect Immun (1998) 0.83

Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis. Int J Nanomedicine (2013) 0.80

Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice. PLoS One (2013) 0.80

AP-1 Transcription Factor Serves as a Molecular Switch between Chlamydia pneumoniae Replication and Persistence. Infect Immun (2015) 0.77

Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain. Pathogenesis (Amst) (1999) 0.76

Quantitative Protein Profiling of Chlamydia trachomatis Growth Forms Reveals Defense Strategies Against Tryptophan Starvation. Mol Cell Proteomics (2016) 0.75

Tryptophan Codon-Dependent Transcription in Chlamydia pneumoniae during Gamma Interferon-Mediated Tryptophan Limitation. Infect Immun (2016) 0.75

The High-Risk Human Papillomavirus E6 Oncogene Exacerbates the Negative Effect of Tryptophan Starvation on the Development of Chlamydia trachomatis. PLoS One (2016) 0.75

Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumtol (2011) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13

Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54

Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64

Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription. Mol Cell Biol (1984) 5.44

Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun (1984) 5.00

Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp. J Bacteriol (1984) 4.99

Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol (1970) 4.96

Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28

Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med (1989) 4.25

Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun (1990) 3.13

Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87

Latency in human infections with TRIC agents. J Immunol (1968) 2.73

Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia. Infect Immun (1971) 2.63

Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun (1994) 2.58

Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis (1988) 2.47

Developmental regulation of tandem promoters for the major outer membrane protein gene of Chlamydia trachomatis. J Bacteriol (1988) 2.24

Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect Immun (1992) 1.99

Nucleoid condensation in Escherichia coli that express a chlamydial histone homolog. Science (1992) 1.87

Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77

Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett (1993) 1.56

Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol (1988) 1.52

Amino acid requirements of strains of Chlamydia trachomatis and C. psittaci growing in McCoy cells: relationship with clinical syndrome and host origin. J Gen Microbiol (1983) 1.39

Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril (1993) 1.29

Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis Suppl (1990) 1.22

Ultrastructure of Chlamydia trachomatis infection of the mouse oviduct. J Ultrastruct Res (1984) 1.20

Miniature cell formation in Chlamydia psittaci. J Bacteriol (1973) 1.14

Diagnosis and prevalence of persistent chlamydia infection in infertile women: tissue culture, direct antigen detection, and serology. Fertil Steril (1991) 1.03

RNA-directed molecular hybridization screening: evidence for inapparent chlamydial infection. Am J Med Sci (1991) 1.02

Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma. Curr Eye Res (1992) 0.98

Sequence diversity of the 60-kilodalton protein and of a putative 15-kilodalton protein between the trachoma and lymphogranuloma venereum biovars of Chlamydia trachomatis. Infect Immun (1991) 0.94

Endocervical chlamydial deoxyribonucleic acid in infertile women. Fertil Steril (1990) 0.93

Articles by these authors

Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev (1994) 4.94

Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun (1986) 4.34

Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28

Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect Immun (1978) 4.26

Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun (1997) 3.12

Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells). Infect Immun (1976) 3.11

A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00

Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin. Infect Immun (1983) 2.77

Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells). Infect Immun (1976) 2.76

Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun (1994) 2.58

A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55

Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol (1994) 2.54

Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53

Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages. J Immunol (1982) 2.40

Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun (1988) 2.30

Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26

Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect Immun (1983) 2.17

Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1990) 2.13

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science (1986) 2.06

Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect Immun (1992) 1.99

Kinetics of phagocytosis of Chlamydia psittaci by mouse fibroblasts (L cells): separation of the attachment and ingestion stages. Infect Immun (1978) 1.94

Lymphokine enhances oxygen-independent activity against intracellular pathogens. J Exp Med (1983) 1.93

Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis (1999) 1.79

Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res (1989) 1.74

Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J Interferon Res (1986) 1.70

Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol (1987) 1.65

Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun (2001) 1.61

A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun (1998) 1.60

Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun (1989) 1.54

IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J Immunol (1993) 1.53

Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation. Infect Immun (1983) 1.53

Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae. Microbes Infect (1999) 1.52

Cytochalasin B does not inhibit ingestion of Chlamydia psittaci by mouse fibroblasts (L cells) and mouse peritoneal macrophages. Infect Immun (1979) 1.48

T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol (1996) 1.48

Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis (1998) 1.46

Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J Infect Dis (1993) 1.44

Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol (1989) 1.41

Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect Immun (1994) 1.41

In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect Immun (2000) 1.36

Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia (1989) 1.33

HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod (2002) 1.29

Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun (2001) 1.28

Arrays of hemispheric surface projections on Chlamydia psittaci and Chlamydia trachomatis observed by scanning electron microscopy. J Bacteriol (1979) 1.26

A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun (1998) 1.25

Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun (1999) 1.25

Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect Immun (1989) 1.20

Reactivation of chlamydial genital tract infection in mice. Infect Immun (1997) 1.17

Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect Immun (2001) 1.15

Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression. J Exp Med (1986) 1.15

Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect Immun (1998) 1.14

In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J Reticuloendothel Soc (1981) 1.12

Effect of interferon on a primary conjunctival epithelial cell model of trachoma. Invest Ophthalmol Vis Sci (1991) 1.11

Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. Infect Immun (1994) 1.10

In vitro expression of factor-mediated cytotoxic activity generated during the immune response to Chlamydia in the mouse. J Immunol (1985) 1.07

Differential susceptibility of chlamydiae to exogenous fibroblast interferon. Infect Immun (1983) 1.07

Serologic responses of infertile women to the 60-kd chlamydial heat shock protein (hsp60). Fertil Steril (1995) 1.04

Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol (1999) 1.04

Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease. Infect Immun (2000) 1.04

Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cell-mediated responses predict tubal factor infertility. Hum Reprod (2006) 1.02

Interactions between macrophages and chlamydiae. Immunol Ser (1994) 0.99

Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells. Infect Immun (1999) 0.99

Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol (2000) 0.98

Use of monoclonal antibodies to facilitate identification, cloning, and purification of Chlamydia trachomatis hsp10. J Clin Microbiol (1997) 0.97

Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1. Cell Immunol (1995) 0.95

Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women. Clin Exp Immunol (2003) 0.92

Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis (2000) 0.92

Immunity to Chlamydia: comparison of human infections and murine models. Res Immunol (1997) 0.92

Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide. Am J Respir Cell Mol Biol (1992) 0.90

Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells. J Rheumatol (1994) 0.90

Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect (2001) 0.89

Role of tryptophan in gamma interferon-mediated chlamydial persistence. Ann N Y Acad Sci (1994) 0.84

Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture. Infect Immun (1998) 0.83

Persistent Chlamydia trachomatis infection: in vitro phenomenon or in vivo trigger of reactive arthritis? J Rheumatol (1998) 0.82

In vivo-activated mononuclear phagocytes and protective immunity to chlamydiae in mice. Infect Immun (1988) 0.80

Chlamydial treatment failures: a persistent problem? J Eur Acad Dermatol Venereol (2001) 0.80

Inducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice. Infect Immun (2003) 0.79

Interferons: from virus inhibitor to modulator of amino acid and lipid metabolism. J Interferon Res (1987) 0.79

Differential modulation of lymphocyte proliferative responses and lymphokine secretion in mice during development of immunity to Chlamydia psittaci. Infect Immun (1989) 0.79

Tryptophan metabolism in chronic inflammatory lung disease. J Lab Clin Med (1995) 0.78

Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication. Adv Exp Med Biol (1983) 0.77

The effect of intracellular Chlamydia psittaci on lysosomal enzyme activities in mouse peritoneal macrophages. Acta Pathol Microbiol Immunol Scand C (1987) 0.76

Identification of a 40-kDa human protein that cross-reacts with prokaryotic hsp60/chaperonins. Biochem Biophys Res Commun (1995) 0.76

QSYP peptide sequence is selected from phage display libraries by bovine IgG contaminants in monoclonal antibody preparations. Biotechniques (2003) 0.76

Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle. J Biol Response Mod (1990) 0.75

Surveillance of patient areas. Hospitals (1971) 0.75

Environmental control programs in health care facilities. Hosp Prog (1971) 0.75